>
Wednesday War Room LIVE: Trump Reveals New Information on Assassination Attempts:
DARPA's high-speed VTOL X-plane passes ground effect testing
Smart stitches generate electricity on movement for faster healing
Corrupt Ukrainian Official's Son Found Lying In Bed With Huge Sum Of Money;
Jeff Bezos's Blue Origin Could Have a Commercial Space Station Running by 2030
Toyota Just Invested $500 Million in Electric Air-Taxi Maker Joby
Cheap, powerful, high-density EV battery cells set for mass production
World's first 3D-printed hotel rises in the Texas desert
Venus Aerospace Unveils Potential Mach 6 Hypersonic Engine and Will Power a Drone in 2025
OpenAI As We Knew It Is Dead, Now It's A Loose Cannon In The Hands Of A Megalomaniac Technocrat
Geothermal Energy Could Outperform Nuclear Power
I Learned How to Fly This Electric Aircraft in a Week--and I Didn't Need a License
"I am Exposing the Whole Damn Thing!" (MIND BLOWING!!!!) | Randall Carlson
Israel develops method for hacking air-gapped computers - no computer is safe now
Yale scientists have now discovered a molecule that can be given to quickly boost their numbers back up, to help fight off infections without antibiotics.
Neutrophils are a type of white blood cell that are among the first responders to foreign threats like bacteria, viruses or fungi. Unfortunately, their levels can drop in a condition called neutropenia, which can be the result of certain genetic conditions or a side effect of a treatments like chemotherapy. In either case, the low neutrophil counts can make infections more serious, and there are few options for boosting them.
In the new study, Yale scientists have identified a molecule that may help. Officially known as A485, and unofficially as "prohiberin," the molecule blocks certain proteins that regulate gene expression, triggering the release of neutrophils and other white blood cells from bone marrow.
In tests in mice, A485 was found to work quickly and only temporarily, with white blood cell counts dropping back to normal by the 12-hour mark. That might sound like a disadvantage, but it's actually a good thing, the team says.
"Currently, the main treatment for low white blood cell counts is G-CSF, or granulocyte colony stimulating factor, which is produced by the body and can be administered as a drug," said Nikolai Jaschke, lead author of the study. "But it has a long-lasting effect, which can be harmful in some circumstances, limiting its wider clinical use. A485 is just as potent as G-CSF but less enduring."